A long-time participant in the push against the rise of antibiotic-resistant infections, Boehringer Ingelheim GmbH has now teamed up with Evotec SE and bioMerieux SA to form a joint venture to improve diagnosis and create the next generation of antimicrobials.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?